Open Access Open Access  Restricted Access Subscription Access

A Review of Understanding Epilepsy: Types, Symptoms, Risks, And Treatment Policies

Renuka Silyas, Meenakshi ., Sharma Sanju, Sanganabasappa Chandrashakhar, Amandeep Kaur

Abstract


Epilepsy is a chronic neurological illness affecting approximately 50 million people globally, making it one of the most neurological situations as per world health organization (WHO). It is characterised by using recurrent unprovoked seizures, epilepsy encompasses numerous subtypes with diverse signs and symptoms and etiologies. This article explores the class, signs, danger elements, treatment modalities, and public fitness rules related to epilepsy, while emphasizing recent facts and international demanding situations in control and care delivery. Globally, spherical 80% of people with epilepsy live in low- and middle-profits countries, wherein remedy get right of entry to its constrained. This remedy gap is normally because of financial constraints, loss of skilled clinical personnel, and social stigma.


Full Text:

PDF

References


 Baker, G. A., et al. (2005). Epilepsy and stigma. Epilepsia, 46(S1), 23–25.

 Berg, A. T., et al. (2010). Revised terminology and ideas for organisation of seizures and epilepsies. Epilepsia, fifty one(4), 676–685.

 Brodie, M. J., et al. (2012). Combining antiepileptic tablets—rational polytherapy. Lancet Neurology, 11(11), 954–964.

 Camfield, C. S., et al. (2002). Idiopathic generalized epilepsy with generalized tonic-clonic seizures handiest. Pediatric Neurology, 26(2), 99–103.

 Camilo, O., & Goldstein, L. B. (2004). Seizures and epilepsy after ischemic stroke. Stroke, 35(7), 1769–1775.

 Fisher, R. S., et al. (2014). a practical medical definition of epilepsy. Epilepsia, fifty five(four), 475–482.

 Fisher, R. S., et al. (2017). Operational type of seizure kinds. Epilepsia, fifty eight(four), 522–530.

 Hauser, W. A., et al. (2007). Seizure disorders after head trauma. Epilepsia, forty eight(Suppl 5), 1–4.

 Kossoff, E. H., et al. (2009). Ketogenic diets in epilepsy: The need for number one care help. Epilepsy & conduct, 14(1), 2–6.

 Kwan, P., et al. (2011). Early identity of refractory epilepsy. Epilepsia, fifty two(5), 943–950.

 Mishra, A., et al. (2020). incapacity repute of humans with epilepsy in India. Indian magazine of Public health, 64(2), one hundred fifty–152.

 Moshé, S. L., et al. (2015). Epilepsy: new advances. Lancet Neurology, 14(6), 681–seven-hundred.

 Ngugi, A. k., et al. (2010). Estimation of the burden of energetic and life-time epilepsy. Epilepsia, 51(five), 883–890.

 Ottman, R., et al. (2010). Genetic affects on epilepsy. Epilepsy Currents, 10(five), 105–a hundred and ten.

 Rajshekhar, V., et al. (2011). Neurocysticercosis in India. Acta Neurological Scandinavica, 123(five), 317–327.

 Scheffer, I. E., et al. (2017). ILAE class of the epilepsies. Epilepsia, fifty eight(4), 512–521.

 Sculier, D., et al. (2018). treatment of repute epilepticus. Epilepsia, 59(four), 146–153.

 Spence, S. J., et al. (2009). Epilepsy in autism spectrum disorders. Pediatrics, 124(five), 1262–1270.

 Wiebe, S., et al. (2001). A randomized trial of surgical operation for temporal-lobe epilepsy. New England journal of medication, 345(five), 311–318.

 global fitness employer. (2023). Epilepsy: Key information. https://www.who.int/news-room/truth-sheets/element/epilepsy


Refbacks

  • There are currently no refbacks.